The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era-Reference-Cited by-同舟云学术

The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era

Published:2016-01 Issue:1 Volume:6 Page:e383-e383
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Kobayashi T,Kuroda J,Yokota I,Tanba K,Fujino T,Kuwahara S,Isa R,Yamaguchi J,Kawata E,Akaogi T,Uchiyama H,Kaneko H,Uoshima N,Kobayashi Y,Teramukai S,Taniwaki M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj2015111.pdf

Reference14 articles.

1. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. New Engl J Med 1993; 329: 987–994.

2. Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P et al. The revised International Prognostic Index (RIPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with RCHOP. Blood 2007; 109: 1857–1861.

3. Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 2014; 123: 837–842.

4. Li X, Zhang Y, Zhao W, Liu Z, Shen Y, Li J et al. The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China. Ann Hematol 2015; 94: 57–63.

5. McMillan DC . Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223–226.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio;International Journal of Hematology;2024-03-16

2. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma;Hematological Oncology;2024-01

3. Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models;Blood Cancer Journal;2023-10-13

4. Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis;Translational Cancer Research;2023-08

5. Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients;Journal of Oncology;2022-11-17